These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 3117843

  • 21. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
    Pottumarthy S, Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
    [Abstract] [Full Text] [Related]

  • 22. Possible prevention of in vitro selection of resistant Streptococcus pneumoniae by beta-lactamase inhibitors.
    Carsenti-Etesse H, Durant J, De Salvador F, Bensoussan M, Bensoussan F, Pradier C, Bernard E, Mondain V, Thabaut A, Dellamonica P.
    Eur J Clin Microbiol Infect Dis; 1994 Dec; 13(12):1058-62. PubMed ID: 7889969
    [Abstract] [Full Text] [Related]

  • 23. Comparison of fixed concentration and fixed ratio options for dilution susceptibility testing of gram-negative bacilli to ampicillin and ampicillin/sulbactam.
    Pfaller MA, Barry AL, Fuchs PC, Gerlach EH, Hardy DJ, McLaughlin JC.
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):356-62. PubMed ID: 8354303
    [Abstract] [Full Text] [Related]

  • 24. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli.
    Jacobs MR, Aronoff SC, Johenning S, Shlaes DM, Yamabe S.
    Antimicrob Agents Chemother; 1986 Jun; 29(6):980-5. PubMed ID: 3015017
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates of Enterobacteriaceae.
    Pfaller M, Barry A, Fuchs P, Gerlach E, Hardy D, McLaughlin J.
    Eur J Clin Microbiol Infect Dis; 1993 Mar; 12(3):200-5. PubMed ID: 8389705
    [Abstract] [Full Text] [Related]

  • 29. In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination.
    Jones RN, Barry AL, Packer RR, Gregory WW, Thornsberry C.
    J Clin Microbiol; 1987 Sep; 25(9):1725-9. PubMed ID: 3498740
    [Abstract] [Full Text] [Related]

  • 30. Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection.
    Retsema JA, English AR, Girard A, Lynch JE, Anderson M, Brennan L, Cimochowski C, Faiella J, Norcia W, Sawyer P.
    Rev Infect Dis; 1986 Sep; 8 Suppl 5():S528-34. PubMed ID: 3026001
    [Abstract] [Full Text] [Related]

  • 31. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study.
    Doern GV, Brueggemann AB, Pierce G, Holley HP, Rauch A.
    Antimicrob Agents Chemother; 1997 Feb; 41(2):292-7. PubMed ID: 9021182
    [Abstract] [Full Text] [Related]

  • 32. In vitro activity of Ro 19-5247 (T-2525) and interpretive criteria for disk diffusion susceptibility testing.
    Beskid G, Fallat V, Siebelist J, Durkin JW, Lipschitz ER, McGarry DH.
    J Clin Microbiol; 1987 Jul; 25(7):1186-90. PubMed ID: 3112176
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [A combination of ampicillin and sulbactam: effect on aerobic and anaerobic gram-negative bacteria].
    González C, García A, Urrea R, del Solar E, Bello H, Zemelman R.
    Rev Med Chil; 1990 May; 118(5):548-54. PubMed ID: 2293275
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Antibacterial activity of the sulbactam-ampicillin combination.
    Sessarego FV, Botta GA, Pesce A, Schito GC.
    J Chemother; 1989 Dec; 1(6):384-7. PubMed ID: 2614505
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.